References

  1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003; 349(16):1543–1554. PubMed | Google Scholar

  2. Hudson C N, Curling M. In: Hudson C N, Editor. Ovarian Cancer. 1985. United Kingdom: Oxford University Press. PubMed | Google Scholar

  3. Dalmau J, Graus F. Paraneoplastic Syndromes of Nervous System. In: Black P, Loeffler J S, Editors. Cancer of the Nervous System. 1997. United States. Blackwell Science.

  4. Brown R H. Paraneoplastic Neurologic Syndromes. In: Fauci et al, Editors. Harrison’s Principles of Internal Medicine 14th ed. 1998. New York. McGraw Hill.

  5. Peterson K, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: a clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992; 42(10):1931-37. PubMed | Google Scholar

  6. Dalmau J, Gonzalez RG, Lerwill MF. Case records of the Massachusetts General Hospital: case 4-2007—a 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med. 2007; 356(6):612–20. PubMed | Google Scholar

  7. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol. 2001;50(3):339–48. PubMed | Google Scholar

  8. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49(2):146–54. PubMed | Google Scholar

  9. Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000; 68(4):479–82. PubMed | Google Scholar

  10. Bradley WH, Dottino PR, Rahaman J. Paraneoplastic cerebellar degeneration in ovarian carcinoma:case report with review of immune modulation. Int J Gynecol Cancer. 2008; 18(6):1364-7. PubMed | Google Scholar

  11. Shams'ili S, Grefkens J, De Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003; 126(1):1409–18. PubMed | Google Scholar